FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicholas Pavlidis

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Disease Progression

Geographic Areas

Greece

Co-author Network

Publications

TOP 3
Konstantinos Kamposioras; George Pentheroudakis; Nicholas Pavlidis
Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks.
George Pentheroudakis; Mats Sanden; Yael Spector; Hila Benjamin; George Fountzilas; Vassiliki Kotoula; Dimitrios Krikelis; Vassiliki Malamou-Mitsi; Eti Meiri; Nicholas Pavlidis; Ranit Aharonov
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
George Fountzilas; Helen Gogas; Konstantine T Kalogeras; Charisios Karanikiotis; George Klouvas; Triantafyllia Koletsa; Ioannis Kostopoulos; Vassiliki Kotoula; Angelos Koutras; Helena Linardou; Christos Papadimitriou; Nicholas Pavlidis; Dimitrios Pectasides; Nikolaos Pisanidis; Epaminondas Samantas; Ioanna Sfakianaki; Despina Televantou; Eleni Timotheadou; Eleftheria Tsolaki; Ioannis Xanthakis; Anna Batistatou; Mattheos Bobos; Urania Dafni; Meletios A Dimopoulos
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicholas Pavlidis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Konstantinos Kamposioras; George Pentheroudakis; Nicholas Pavlidis
Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks.
European journal of clinical investigation 2013;43(5):491-500.
2013: George Pentheroudakis; Mats Sanden; Yael Spector; Hila Benjamin; George Fountzilas; Vassiliki Kotoula; Dimitrios Krikelis; Vassiliki Malamou-Mitsi; Eti Meiri; Nicholas Pavlidis; Ranit Aharonov
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
Clinical & experimental metastasis 2013;30(4):431-9.
2013: George Fountzilas; Helen Gogas; Konstantine T Kalogeras; Charisios Karanikiotis; George Klouvas; Triantafyllia Koletsa; Ioannis Kostopoulos; Vassiliki Kotoula; Angelos Koutras; Helena Linardou; Christos Papadimitriou; Nicholas Pavlidis; Dimitrios Pectasides; Nikolaos Pisanidis; Epaminondas Samantas; Ioanna Sfakianaki; Despina Televantou; Eleni Timotheadou; Eleftheria Tsolaki; Ioannis Xanthakis; Anna Batistatou; Mattheos Bobos; Urania Dafni; Meletios A Dimopoulos
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC cancer 2013;13():163.
2013: George Pentheroudakis; Evangelia Razis; Joseph Sgouros; Sabine Tejpar; Despina Televantou; Athanassios C Tsamandas; Ioannis Xanthakis; Dimitrios Bafaloukos; Iliada Bompolaki; Wendy De Roock; Ioannis Efstratiou; Eleni Galani; Georgia Kafiri; Vassiliki Kotoula; George Kouvatseas; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; Nicholas Pavlidis; Dimitrios Pectasides; George Fountzilas
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
BMC cancer 2013;13():49.
2012: Vassilis Golfinopoulos; Ann C Goussia; D Krikelis; Vassiliki Malamou-Mitsi; Marios Marselos; Mattheos Bobos; A Cervantes; tudor ciuleanu; George Fountzilas; George Pentheroudakis; V Siozopoulou; Nicholas Pavlidis
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2725-30.
2012: Nicholas Pavlidis; Vassilis Golfinopoulos; Dimitrios Petrakis; George Pentheroudakis
Long-term survivors among patients with cancer of unknown primary.
Critical reviews in oncology/hematology 2012;84(1):85-92.
2012: George Pentheroudakis; Jan Vermorken; Andres Cervantes; Dimitrios Krikelis; Nicholas Pavlidis
Profiling clinical cancer research across the Atlantic: a review of research and its characteristics presented at ASCO and ESMO Congresses during the last decade.
Cancer treatment reviews 2012;38(6):560-5.
2012: Nicholas Pavlidis
Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23 Suppl 10():x282-5.
2012: Dimitrios Krikelis; Vassiliki Malamou-Mitsi; Mattheos Bobos; Andres Cervantes; tudor ciuleanu; George Fountzilas; Vassilis Golfinopoulos; Ann C Goussia; George Pentheroudakis; Dimitrios Petrakis; Vassiliki Siozopoulou; Aikaterini Stoyianni; Nicholas Pavlidis
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
Clinical & experimental metastasis 2012;29(6):603-14.
2012: George Pentheroudakis; A Tsigka; Konstantinos Vlachtsis; N Angouridakis; A G Eleftheraki; E Fountzilas; A Fragkoulidi; I Karasmanis; V Kotoula; K Markou; I Nicolaou; A Nikolaou; Nicholas Pavlidis; George Fountzilas
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.
Oral oncology 2012;48(8):709-16.
2012: Nicholas Pavlidis; Giorgio Stanta; Riccardo A Audisio
Cancer prevalence and mortality in centenarians: a systematic review.
Critical reviews in oncology/hematology 2012;83(1):145-52.
2012: Nicholas Pavlidis; George Pentheroudakis
Cancer of unknown primary site.
Lancet 2012;379(9824):1428-35.
2012: Aikaterini Stoyianni; George Pentheroudakis; Vassiliki Siozopoulou; Sofia Bellou; Mattheos Bobos; Andres Cervantes; Theodore Fotsis; Georgios Fountzilas; Vassilis Golfinopoulos; Ann C Goussia; Elli Ioachim; Dimitrios Krikelis; Vassiliki Malamou-Mitsi; Nicholas Pavlidis
Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
Anticancer research 2012;32(4):1273-81.
2012: Panagiota Goulia; André F Carvalho; Alexandros A Drosos; Myrela O Machado; Christos Mantas; Ilias Papadimitriou; Christina Pappa; Nicholas Pavlidis; Epameinondas Tsianos; Thomas Hyphantis
Does psychological distress vary between younger and older adults in health and disease?
Journal of psychosomatic research 2012;72(2):120-8.
2012: Elias Kotteas; Eli Ioachim; Nicholas Pavlidis
A pregnant patient with adrenocortical carcinoma: case report.
Onkologie 2012;35(9):517-9.
2011: S Boussios; Sevasti Kamina; K Katsanos; George Pentheroudakis; Nicholas Pavlidis
Docetaxel-induced enterocolitis: a serious and potentially fatal adverse event.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(4):778-9.
2011: Nicholas Pavlidis
Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer?
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S348-52.
2011: Nicholas Pavlidis; R Stahel; H Hansen; A Cervantes
Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22 Suppl 6():vi7-11.
2011: Aikaterini Stoyianni; George Pentheroudakis; Nicholas Pavlidis
Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors.
Cancer treatment reviews 2011;37(5):358-65.
2011: E Voulgaris; George Pentheroudakis; Lina S Pappa; Maria Bafa; Ann C Goussia; P Dalezis; C Tsombanidou; G Geromichalos; Athanasios Papageorgiou; M Koutsilieris; Vassiliki Malamou-Mitsi; Nicholas Pavlidis
Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases.
Lung cancer (Amsterdam, Netherlands) 2011;73(1):51-8.
2011: Thomas Hyphantis; Vassiliki Paika; Augoustina Almyroudi; Eleftherios O Kampletsas; Nicholas Pavlidis
Personality variables as predictors of early non-metastatic colorectal cancer patients' psychological distress and health-related quality of life: a one-year prospective study.
Journal of psychosomatic research 2011;70(5):411-21.
2011: George Pentheroudakis; Anna Batistatou; Konstantine T Kalogeras; Ralf Kronenwett; Ralph M Wirtz; Evangelos Bournakis; Anastasia G Eleftheraki; Dimitrios Pectasides; Mattheos Bobos; Irini Papaspirou; Sevasti Kamina; Helen Gogas; Angelos K Koutras; Nicholas Pavlidis; George Fountzilas
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Breast cancer research and treatment 2011;127(1):179-93.
2011: George Pentheroudakis; Aikaterini Stoyianni; Nicholas Pavlidis
Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis?
Cancer treatment reviews 2011;37(2):120-6.
2011: Lida Kostadima; George Pentheroudakis; Nicholas Pavlidis
Recurrent episodes of recall dermatitis of irradiated breast after LHRH agonist administration.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(1):183-4.
2010: Nicholas Pavlidis; George Pentheroudakis
Cancer of unknown primary site: 20 questions to be answered.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii303-7.
2010: Nicholas Pavlidis; W Gatzemeier; R Popescu; R Stahel; HERBERT PINEDO; F Cavalli; A Costa
The masterclass of the european school of oncology: the 'key educational event' of the school.
European journal of cancer (Oxford, England : 1990) 2010;46(12):2159-65.
2010: George Pentheroudakis; Ann C Goussia; Evangelos Voulgaris; Konstantinos Nikolaidis; Evaggelia Ioannidou; Alexandra Papoudou-Bai; Konstantina Grepi; Panagiotis Kanavaros; Nicholas Pavlidis; Maria Bai
High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment.
Leukemia & lymphoma 2010;51(7):1260-8.
2010: George Pentheroudakis; Nicholas Pavlidis
Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review.
Critical reviews in oncology/hematology 2010;75(1):27-42.
2010: George Pentheroudakis; Nicholas Pavlidis
Probing the unknown in cancer of unknown primary: which way is the right way?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1143-4.
2010: George Pentheroudakis; R Orecchia; H J Hoekstra; Nicholas Pavlidis
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v266-73.
2010: Nicholas Pavlidis; Evangelos Briasoulis; George Pentheroudakis
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v228-31.
2010: Vassiliki Paika; Augoustina Almyroudi; Barbara Tomenson; Francis Creed; Eleftherios O Kampletsas; Vassiliki Siafaka; Styliani Gkika; Venetsanos Mavreas; Nicholas Pavlidis; Thomas Hyphantis
Personality variables are associated with colorectal cancer patients' quality of life independent of psychological distress and disease severity.
Psycho-oncology 2010;19(3):273-82.
2010: George Pentheroudakis; George Lazaridis; Nicholas Pavlidis
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence.
Breast cancer research and treatment 2010;119(1):1-11.
2009: Thomas Hyphantis; Barbara Tomenson; Vassiliki Paika; Augoustina Almyroudi; Chrisavgi Pappa; Niki Tsifetaki; Paraskevi V Voulgari; Alexandros A Drosos; Nicholas Pavlidis; Francis Creed
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(8):1029-42.
2009: Nicholas Pavlidis
Evidence-based medicine: development and implementation of guidelines in oncology.
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():468-70.
2009: George Pentheroudakis; Konstantine T Kalogeras; Ralph M Wirtz; Irene Grimani; George Zografos; Helen Gogas; Udo Stropp; Dimitrios Pectasides; Dimosthenis Skarlos; Guido Hennig; Epaminondas Samantas; Dimitrios Bafaloukos; Pavlos Papakostas; Haralabos P Kalofonos; Nicholas Pavlidis; George Fountzilas
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast cancer research and treatment 2009;116(1):131-43.
2009: Nicholas Pavlidis; George Pentheroudakis; George Plataniotis
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2009;11(6):340-8.
2009: Nicholas Pavlidis; H Hansen; R Stahel
ESMO clinical recommendations: using the easier and faster approach to oncology guidelines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():7-9.
2009: George Pentheroudakis; Nicholas Pavlidis; M Castiglione
Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():178-81.
2009: Evangelos Briasoulis; Nicholas Pavlidis; E Felip
Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():154-5.
2009: E Voulgaris; George Pentheroudakis; Amalia Vassou; Nicholas Pavlidis
Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2009;64(2):247-9.
2009: George Pentheroudakis; F A Greco; Nicholas Pavlidis
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
Cancer treatment reviews 2009;35(3):221-7.
2009: Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Ivan Cortinovis; Vasiliki Karampoiki; Evridiki Loukidou; Paraskevi Alevizaki; Konstantinos Kamposioras; Georgios Kouris; Parthenopi Alexandropoulou; Lamprini Tsali; Charalampos Panou; Athanasios Stamatelopoulos; Velisarios Lakiotis; Anastasia Spiliopoulou; Aikaterini Terzoudi; Aliki Ioakimidou; Ioanna Karathanasi; Magdalini Bristianou; Giovanni Casazza; Nicholas Pavlidis
Screening practice and misplaced priorities.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2009;11(4):228-36.
2009: Nicholas Pavlidis; Karim Fizazi
Carcinoma of unknown primary (CUP).
Critical reviews in oncology/hematology 2009;69(3):271-8.
2009: George Pentheroudakis; Nikolaos Angouridakis; Ralph Wirtz; Angelos Nikolaou; Konstantine T Kalogeras; Nicholas Pavlidis; George Fountzilas
Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.
Journal of oncology 2009;2009():854127.
2009: Vassilis Golfinopoulos; Vassilis Golfinopouloss; George Pentheroudakis; Smaragda Kamakari; Vasiliki Metaxa-Mariatou; Nicholas Pavlidis
Donor-derived breast cancer in a bone marrow transplantation recipient.
Breast cancer research and treatment 2009;113(2):211-3.
2008: George Pentheroudakis; R Stahel; H Hansen; Nicholas Pavlidis
Heterogeneity in cancer guidelines: should we eradicate or tolerate?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(12):2067-78.
2008: George Lazaridis; George Pentheroudakis; George Fountzilas; Nicholas Pavlidis
Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Cancer treatment reviews 2008;34(8):693-700.
2008: Vassiliki Siafaka; Thomas Hyphantis; I Alamanos; Georgios Fountzilas; Demosthenis Skarlos; Demetrios Pectasides; Venetsanos Mavreas; Nicholas Pavlidis
Personality factors associated with psychological distress in testicular cancer survivors.
Journal of personality assessment 2008;90(4):348-55.
2008: Evangelos Briasoulis; George Fountzilas; A Bamias; M A Dimopoulos; N Xiros; Gerasimos Aravantinos; Epaminondas Samantas; H Kalofonos; T Makatsoris; N Mylonakis; P Papakostas; D Skarlos; I Varthalitis; Nicholas Pavlidis
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer chemotherapy and pharmacology 2008;62(2):277-84.
2008: Evangelos Briasoulis; Nicholas Pavlidis; E Felip
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 2():ii106-7.
2008: Evangelos Briasoulis; Konstantinos Kamposioras; Vasilis Tzovaras; George Pafitanis; Angeliki Kostoula; Anestis Mavridis; Nicholas Pavlidis
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):302-6.
2008: George Papaxoinis; George Fountzilas; DEMETRA RONTOGIANNI; Meletios A Dimopoulos; Nicholas Pavlidis; Costas Tsatalas; Dimitrios Pectasides; Nikolaos Xiros; Theofanis Economopoulos
Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):780-6.
2008: Konstantinos Kamposioras; George Pentheroudakis; Vassiliki Malamou-Mitsi; Lina Pappa; Maria Bafa; Nicholas Pavlidis
Can circulated lung cancer cells pass to the urine without apparent urine tract metastases? A single centre series.
Lung cancer (Amsterdam, Netherlands) 2008;60(1):141-5.
2008: George Lazaridis; George Pentheroudakis; Nicholas Pavlidis
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety.
Critical reviews in oncology/hematology 2008;66(1):31-41.
2008: George Pentheroudakis; Evangelos Briasoulis; Haralabos P Kalofonos; George Fountzilas; Theofanis Economopoulos; Georgios Fotios Samelis; Aris Koutras; Maria Karina; Nikolaos Xiros; Epaminondas Samantas; Aristotelis Bamias; Nicholas Pavlidis
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1148-55.
2007: Paris A Kosmidis; George Fountzilas; S Baka; Epaminondas Samantas; Athanassios Meletios Dimopoulos; Helen Gogas; Dimosthenis Skarlos; P Papacostas; J Boukovinas; Ch Bakogiannis; P Pantelakos; H Athanasiou; Despina Misailidou; Pericles G Tsekeris; Nicholas Pavlidis
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer research 2007;27(6C):4391-5.
2007: Markus Joerger; Alwin D R Huitema; Dick J Richel; Christian Dittrich; Nicholas Pavlidis; Evangelos Briasoulis; Jan B Vermorken; Elena Strocchi; Andrea Martoni; Roberto Sorio; Henk P Sleeboom; Miguel A Izquierdo; Duncan I Jodrell; Hilary Calvert; Alan V Boddy; Harry Hollema; Regine Féty; Wjf J F Van der Vijgh; Georg Hempel; Etienne Chatelut; Mats Karlsson; Justin Wilkins; Brigitte Tranchand; Ad H G J Schrijvers; Chris Twelves; Jos H Beijnen; Jan H M Schellens
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6410-8.
2007: George Pentheroudakis; Nicholas Pavlidis
Late toxicity in survivors from adolescent cancers.
Cancer treatment reviews 2007;33(7):656-63.
2007: Vassilis Golfinopoulos; Georgia Salanti; Nicholas Pavlidis; John Ioannidis
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.
The lancet oncology 2007;8(10):898-911.
2007: George Pentheroudakis; Periklis Pappas; Vassilis Golfinopoulos; George Fountzilas; Martha Nikolaidou; Vassiliki A Boumba; Theodre Vougiouklakis; L Nikiforidis; Eleftheria Tzamakou; O Siarabi; Marios Marselos; Nicholas Pavlidis
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
Cancer chemotherapy and pharmacology 2007;60(5):733-9.
2007: George Pentheroudakis; Vassilis Golfinopoulos; Nicholas Pavlidis
Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2026-36.
2007: Nicholas Pavlidis; J B Vermorken; R Stahel; J Bernier; A Cervantes; R Audisio; George Pentheroudakis; A Costa
Oncology for medical students: a European School of Oncology contribution to undergraduate cancer education.
Cancer treatment reviews 2007;33(5):419-26.
2007: Lida Kostadima; George Pentheroudakis; Nicholas Pavlidis
The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer.
Anticancer research 2007;27(4B):2499-504.
2007: Nicholas Pavlidis
Towards a convenient way to practice medical oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 2():ii3-4.
2007: George Pentheroudakis; Evangelos Briasoulis; Nicholas Pavlidis
Cancer of unknown primary site: missing primary or missing biology?
The oncologist 2007;12(4):418-25.
2007: Spyridon Tzioras; Nicholas Pavlidis; Evangelos Paraskevaidis; John Ioannidis
Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.
Cancer treatment reviews 2007;33(1):24-38.
2007: Nicholas Pavlidis
Forty years experience of treating cancer of unknown primary.
Acta oncologica (Stockholm, Sweden) 2007;46(5):592-601.
2007: Leukothea Dova; George Pentheroudakis; Ioannis Georgiou; Vassiliki Malamou-Mitsi; George Vartholomatos; George Fountzilas; Nikolaos Kolaitis; Evangelia Kitsiou; Nicholas Pavlidis
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?
Clinical & experimental metastasis 2007;24(2):79-86.
2006: George Pentheroudakis; Nicholas Pavlidis
Perspectives for targeted therapies in cancer of unknown primary site.
Cancer treatment reviews 2006;32(8):637-44.
2006: Davide Mauri; Konstantinos Kamposioras; Anastasios Proiskos; Apostolos Xilomenos; Christina Peponi; Mario Dambrosio; Georgios Zacharias; Georgios Koukourakis; George Pentheroudakis; Nicholas Pavlidis
Old habits die hard: chest radiography for screening purposes in primary care.
The American journal of managed care 2006;12(11):650-6.
2006: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Christina Piperidou; Kali Soulti; Nicholas Pavlidis
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction.
Anti-cancer drugs 2006;17(10):1219-22.
2006: Lida Kostadima; George Pentheroudakis; George Fountzilas; Meletios A Dimopoulos; Dimitrios Pectasides; Helen Gogas; Udo Stropp; Christos Christodoulou; Epaminondas Samantas; Ralph Wirtz; Guido Hennig; Dimitrios Bafaloukos; P Arapantoni; Haralambos Kalofonos; Pavlos Papakostas; Theofanis Economopoulos; Aristotelis Bamias; Nicholas Pavlidis
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
Breast cancer research and treatment 2006;100(2):161-7.
2006: George Papaxoinis; Sotirios Papageorgiou; DEMETRA RONTOGIANNI; Vassiliki Kaloutsi; George Fountzilas; Nicholas Pavlidis; Meletios A Dimopoulos; Costas Tsatalas; Nikolaos Xiros; Theofanis Economopoulos
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
Leukemia & lymphoma 2006;47(10):2140-6.
2006: George Fountzilas; Pavlos Papakostas; Urania Dafni; Thomas Makatsoris; Maria Karina; Anna Kalogera-Fountzila; N Maniadakis; Gerasimos Aravantinos; Konstantinos Syrigos; Aristotelis Bamias; Christos Christodoulou; Theofanis Economopoulos; Haralambos Kalofonos; Angelos Nikolaou; N Angouridakis; George P Stathopoulos; Dimitrios Bafaloukos; Nicholas Pavlidis; John Daniilidis
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1560-7.
2006: Davide Mauri; Nicholas Pavlidis; Nikolaos P Polyzos; John Ioannidis
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Journal of the National Cancer Institute 2006;98(18):1285-91.
2006: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Helen Efstathiou; Dimitrios Farmakis; Dimosthenis Skarlos; Nicholas Pavlidis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
2006: George Pentheroudakis; Konstantinos Neanidis; Lida Kostadima; George Fountzilas; Nicholas Pavlidis
Elderly patients with squamous lung carcinoma: faring better or worse?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(8):867-70.
2006: Davide Mauri; George Pentheroudakis; Dimitrios Bafaloukos; Dimitrios Pectasides; Epaminondas Samantas; Eleni Efstathiou; Haralabos P Kalofonos; Konstantinos Syrigos; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; George Fountzilas; Nicholas Pavlidis
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
2006: George Pentheroudakis; Davide Mauri; Lida Kostadima; Vassilis Golfinopoulos; George Alexiou; Anestis Karakatsanis; Nicholas Pavlidis
"Juvenile" oncology--a missing subspecialty. The experience of a reference cancer centre.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2006;8(6):444-9.
2006: Nektaria Zagorianakou; Dimitrios Stefanou; George Makrydimas; P Zagorianakou; Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Histology and histopathology 2006;21(4):341-7.
2006: Nikolaos P Polyzos; Nicholas Pavlidis; Evangelos Paraskevaidis; John Ioannidis
Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
European journal of cancer (Oxford, England : 1990) 2006;42(3):319-26.
2006: Vassilis Golfinopoulos; George Pentheroudakis; Nicholas Pavlidis
Treatment of colorectal cancer in the elderly: a review of the literature.
Cancer treatment reviews 2006;32(1):1-8.
2006: George Pentheroudakis; E Razis; A Athanassiadis; Nicholas Pavlidis; George Fountzilas
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety.
Medical oncology (Northwood, London, England) 2006;23(2):147-60.
2006: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Nicholas Pavlidis
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():241-6.
2006: Davide Mauri; George Pentheroudakis; Athanasios Milousis; Apostolos Xilomenos; Evaggelia Panagoulopoulou; Magdalini Bristianou; Georgios Zacharias; Dimitrios Christidis; Evaggelia Aikaterini Mustou; Athanasia Gkinosati; Nicholas Pavlidis
Colorectal cancer screening awareness in European primary care.
Cancer detection and prevention 2006;30(1):75-82.
2006: George Pentheroudakis; Nicholas Pavlidis
Cancer and pregnancy: poena magna, not anymore.
European journal of cancer (Oxford, England : 1990) 2006;42(2):126-40.
2005: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Matrix metalloproteinases in carcinoma of unknown primary.
Cancer 2005;104(10):2282-7.
2005: Evangelos Briasoulis; Epaminondas Samantas; Haralambos Kalofonos; Dimosthenis Skarlos; Thomas Makatsoris; Christos Christodoulou; George Fountzilas; Aristotelis Bamias; M A Dimopoulos; Paris A Kosmidis; Nicholas Pavlidis
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
2005: Theofanis Economopoulos; Sotirios Papageorgiou; DEMETRA RONTOGIANNI; Vassiliki Kaloutsi; George Fountzilas; Costas Tsatalas; Nicholas Pavlidis; Dimitrios Pectasides; Efstathios Papageorgiou; Meletios A Dimopoulos
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.
The oncologist 2005;10(9):734-8.
2005: Nicholas Pavlidis; George Pentheroudakis
The pregnant mother with breast cancer: diagnostic and therapeutic management.
Cancer treatment reviews 2005;31(6):439-47.
2005: Periklis Pappas; Vasilis Karavasilis; Evangelos Briasoulis; Nicholas Pavlidis; Marios Marselos
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
Cancer chemotherapy and pharmacology 2005;56(4):358-60.
2005: Davide Mauri; George Pentheroudakis; Christos Tolis; Marzanna Chojnacka; Nicholas Pavlidis
Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Urologic oncology 2005;23(5):318-22.
2005: Dimitrios Pectasides; Gerasimos Aravantinos; George Fountzilas; Charalambos Kalofonos; Eleni Efstathiou; Maria Karina; Nicholas Pavlidis; Dimitrios Farmakis; Theofanis Economopoulos; Meletios A Dimopoulos
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
2005: Efstathios Papageorgiou; Panagiotis Tsirigotis; Meletios A Dimopoulos; Nicholas Pavlidis; George Fountzilas; Sotirios Papageorgiou; Theofanis Economopoulos
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
European journal of haematology 2005;75(2):124-9.
2005: Dimosthenis V Skarlos; Haralabos P Kalofonos; George Fountzilas; Meletios A Dimopoulos; Nicholas Pavlidis; Evangelia Razis; Theofanis Economopoulos; Dimitrios Pectasides; Helen Gogas; Paris A Kosmidis; Dimitrios Bafaloukos; George Klouvas; George Kyratzis; Gerasimos Aravantinos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Skarlos; Haralabos P Kalofonos; Christos Papadimitriou; Dimitrios Bafaloukos; Stefanos Lambropoulos; Savvas Papadopoulos; Helen P Kourea; Christos Markopoulos; Helena Linardou; Dimitrios Mavroudis; Evangelos Briasoulis; Nicholas Pavlidis; Evangelia Razis; Paris A Kosmidis; Helen Gogas
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Evangelos Briasoulis; DEMETRA RONTOGIANNI; Vasilis Karavasilis; Nicholas Pavlidis
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2005;15(6):614-7.
2005: George Pentheroudakis; Nicholas Pavlidis
Management of leptomeningeal malignancy.
Expert opinion on pharmacotherapy 2005;6(7):1115-25.
2005: Konstantinos S Polyzoidis; George Miliaras; Nicholas Pavlidis
Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma.
Cancer treatment reviews 2005;31(4):247-55.
2005: Nicholas Pavlidis; Karim Fizazi
Cancer of unknown primary (CUP).
Critical reviews in oncology/hematology 2005;54(3):243-50.
2005: George Pentheroudakis; Evangelos Briasoulis; V Karavassilis; Davide Mauri; Eleftheria Tzamakou; Dimitra Rammou; Nicholas Pavlidis
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Chemotherapy 2005;51(2-3):154-61.
2005: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.
BMC cancer 2005;5():25.
2005: Davide Mauri; Nicholas Pavlidis; John Ioannidis
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
Journal of the National Cancer Institute 2005;97(3):188-94.
2005: George Pentheroudakis; Nicholas Pavlidis
Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):181-8.
2005: Aristotelis Bamias; George Basdanis; Ioannis Xanthakis; Nicholas Pavlidis; George Fountzilas
Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.
International journal of gastrointestinal cancer 2005;36(1):29-38.
2005: George Fountzilas; Christos Tolis; Anna Kalogera-Fountzila; Despina Misailidou; Pericles G Tsekeris; Maria Karina; Angelos Nikolaou; Epaminondas Samantas; Thomas Makatsoris; Eleni Athanassiou; Dimosthenis Skarlos; Aristotelis Bamias; Nikolaos Zamboglou; Theofanis Economopoulos; Sophia Karanastassi; Nicholas Pavlidis; John Daniilidis
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.
Medical oncology (Northwood, London, England) 2005;22(3):269-79.
2005: E Briasoulis; Christos Tolis; J Bergh; Nicholas Pavlidis
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 1():i75-6.
2005: Theofanis Economopoulos; Sotirios Papageorgiou; Meletios A Dimopoulos; Nicholas Pavlidis; Costas Tsatalas; Argyris Symeonidis; A Foudoulakis; Dimitrios Pectasides; DEMETRA RONTOGIANNI; E Rizos; Panagiota Chalkia; A Anagnostopoulos; Maria Melachrinou; Efstathios Papageorgiou; George Fountzilas
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Acta haematologica 2005;113(2):97-103.
2005: George Pentheroudakis; Evangelos Briasoulis; Vassilis Karavassilis; George Fountzilas; Nikolaos Xeros; Georgios Fotios Samelis; Epaminondas Samantas; Nicholas Pavlidis
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?
Acta oncologica (Stockholm, Sweden) 2005;44(2):155-60.
2004: Elena Tsanou; Elli Ioachim; Evangelos Briasoulis; Antonia Charchanti; Konstantina Damala; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Journal of experimental & clinical cancer research : CR 2004;23(4):641-50.
2004: George Pentheroudakis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Konstantina Damala; Amalia Vassou; George Vartholomatos; Nikolaos Kolaitis; Nicholas Pavlidis
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
Cancer 2004;101(8):1767-75.
2004: Aristotelis Bamias; Konstantinos Syrigos; George Fountzilas; Eleftheria Tzamakou; Kali Soulti; Vasilis Karavasilis; Yiannis Alamanos; Christos Christodoulou; Nicholas Pavlidis
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study.
American journal of clinical oncology 2004;27(5):465-71.
2004: Evangelos Briasoulis; George Pentheroudakis; Vasilis Karavasilis; Eleftheria Tzamakou; Dimitra Rammou; Nicholas Pavlidis
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1566-73.
2004: Evangelos Briasoulis; Vasilis Karavasilis; Lida Kostadima; Michael Ignatiadis; George Fountzilas; Nicholas Pavlidis
Metastatic breast carcinoma confined to bone: portrait of a clinical entity.
Cancer 2004;101(7):1524-8.
2004: Davide Mauri; P Pazarlis; Jacopo Mauri; Hilal Altinoz; F J Rivas Flores; Irini Karentzou; Anastasios Proiskos; Velisarios Lakiotis; Angeliki Maragkaki; E Terzoudi; E M Dambrosio; Anastasia Spiliopoulou; A Varsami; P Alexandropoulou; C Tolis; Nicholas Pavlidis; Angeliki Vittoraki
SESy-Europe: a multi-language database dedicated to cancer screening monitoring.
Journal of experimental & clinical cancer research : CR 2004;23(3):441-5.
2004: Evangelos Briasoulis; George Pentheroudakis; H Timotheadou; Dimitra Rammou; Nicholas Pavlidis; George Fountzilas
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study.
Anti-cancer drugs 2004;15(8):747-52.
2004: A Karpozilos; Nicholas Pavlidis
The treatment of cancer in Greek antiquity.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2033-40.
2004: George Pentheroudakis; Lida Kostadima; George Fountzilas; A Kalogera-Fountzila; George Klouvas; Charalambos Kalofonos; Nicholas Pavlidis
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features.
Lung cancer (Amsterdam, Netherlands) 2004;45(3):349-55.
2004: Elena Tsanou; Elli Ioachim; Evangelos Briasoulis; Konstantina Damala; Antonia Charchanti; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma.
Histology and histopathology 2004;19(3):807-13.
2004: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Dimitra Rammou; Kali Soulti; Christina Piperidou; Nicholas Pavlidis
Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel.
Cancer chemotherapy and pharmacology 2004;53(5):452-7.
2004: George Fountzilas; George P Stathopoulos; George Kouvatseas; A Polychronis; George Klouvas; Epaminondas Samantas; Nikolaos Zamboglou; K Kyriakou; Adamos Adamou; D Pectasidis; Th Ekonomopoulos; Haralabos P Kalofonos; Dimitrios Bafaloukos; Vassilis Georgoulias; Evangelia Razis; Dimitrios Koukouras; V Zombolas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Nicholas Pavlidis
The diagnostic and therapeutic management of leptomeningeal carcinomatosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv285-91.
2003: Evangelos Briasoulis; Nicholas Pavlidis; C Terret; J Bauer; W Fiedler; P Schöffski; J L Raoul; D Hess; R Selvais; D Lacombe; P Bachmann; Pierre Fumoleau
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2334-40.
2003: John Ioannidis; Anastasia Polycarpou; Christos Ntais; Nicholas Pavlidis
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2278-87.
2003: Nicholas Pavlidis; Evangelos Briasoulis; J Hainsworth; F A Greco
Diagnostic and therapeutic management of cancer of an unknown primary.
European journal of cancer (Oxford, England : 1990) 2003;39(14):1990-2005.
2003: Gerasimos Aravantinos; Dimitrios Bafaloukos; G Fountzilas; C Christodoulou; Christos Papadimitriou; Nicholas Pavlidis; H P Kalofonos; H Gogas; Paris A Kosmidis; Meletios A Dimopoulos
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1094-9.
2003: Dimosthenis V Skarlos; Athanassios Meletios Dimopoulos; Paris A Kosmidis; Pavlos Papakostas; Nicholas Pavlidis; Christos Bacoyiannis; Christos Kiamouris; George Klouvas; Helen Gogas; George Fountzilas; Epaminondas Samantas
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):107-11.
2003: Vasilis Karavasilis; Evangelos Briasoulis; Olga Siarabi; Nicholas Pavlidis
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapy.
Clinical prostate cancer 2003;2(1):46-9.
2003: Aristotelis Bamias; Maria C Bai; Niki J Agnantis; Michael C Michael; Yiannis P Alamanos; Stella V Stefanaki; Evangelia Razi; Dimosthenis V Skarlos; Angelos M Kappas; Nicholas Pavlidis
Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Cancer investigation 2003;21(3):333-40.
2003: John Ioannidis; Nicholas Pavlidis
Levels of absolute survival benefit for systemic therapies of advanced cancer. a call for standards.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1194-8.
2003: Elli Ioachim; Elena Tsanou; Evangelos Briasoulis; Ch Batsis; Vasilis Karavasilis; Antonia Charchanti; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.
Breast (Edinburgh, Scotland) 2003;12(2):111-9.
2003: Evagelos N Liberopoulos; Christos Tolis; Mary Bai; Stavros C Efremidis; Nicholas Pavlidis; Moses Elisaf
Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.
Oncology 2003;65(2):182-6.
2003: Nicholas Pavlidis
Cancer of unknown primary: biological and clinical characteristics.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 3():iii11-8.
2003: Theofanis Economopoulos; George Fountzilas; Nicholas Pavlidis; Dimitris Kalantzis; Efstathios Papageorgiou; Christos Christodoulou; George Hamilos; Costas Nicolaides; Meletios A Dimopoulos
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(2):110-5.
2003: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Kalofonos; N Timotheadou; V Siafaka; I Vlahou; D Janinis; Dimitrios Pectasides; Nicholas Pavlidis; George Fountzilas
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
Oncology 2003;64(2):102-10.
2002: Elli Ioachim; Antonia Charchanti; Evangelos Briasoulis; Vasilis Karavasilis; H Tsanou; Dimitrios Arvanitis; Niki J Agnantis; Nicholas Pavlidis
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
European journal of cancer (Oxford, England : 1990) 2002;38(18):2362-70.
2002: C Christodolou; Nicholas Pavlidis; Epaminondas Samantas; George Fountzilas; George Kouvatseas; K Pagdatoglou; F Palamidas; C Nikolaidis; M Angelidou; Haralabos P Kalofonos; Paris A Kosmidis; Dimosthenis V Skarlos
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Anticancer research 2002;22(6B):3749-57.
2002: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Constantina Haidou; Christina Piperidou; Nicholas Pavlidis
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study.
Anti-cancer drugs 2002;13(5):481-9.
2002: Eleni Andreopoulou; Demetrios M Andreopoulos; Konstantinos Adamidis; A Fountzila-Kalogera; George Fountzilas; Meletios A Dimopoulos; Gerasimos Aravantinos; N Zamboglou; D Baltas; Nicholas Pavlidis
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.
Anticancer research 2002;22(3):1903-8.
2002: Theofanis Economopoulos; Meletios A Dimopoulos; Sofia Mellou; Nicholas Pavlidis; Epaminondas Samantas; Costas Nicolaides; Costas Tsatalas; A Papadopoulos; E Papageogriou; P Papasavvas; George Fountzilas
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
European journal of haematology 2002;68(3):135-43.
2002: J H M Schellens; B Heinrich; M Lehnert; M E Gore; S B Kaye; Per Dombernowsky; Robert Paridaens; A T van Oosterom; Jaap Verweij; Walter J Loos; Hilary Calvert; Nicholas Pavlidis; H Cortes-Funes; Jantien Wanders; MW Roelvink; Cristiana Sessa; K Selinger; Paul Wissel; Teresa Gamucci; Axel R Hanauske
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies.
Investigational new drugs 2002;20(1):83-93.
2002: Haralabos P Kalofonos; Costas Nicolaides; Epaminondas Samantas; Nicolas Mylonakis; Gerasimos Aravantinos; Meletios A Dimopoulos; Constantinos Gennatas; George Kouvatseas; Eleftherios Giannoulis; Christos Dervenis; George Basdanis; Nicholas Pavlidis; Ioannis Androulakis; George Fountzilas
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
2002: Christos Bacoyiannis; Meletios A Dimopoulos; Haralabos P Kalofonos; Costas Nicolaides; Gerasimos Aravantinos; Dimitrios Bafaloukos; Georgios Fotios Samelis; Adimchi Onyenadum; Christos Kiamouris; Dimosthenis Skarlos; Nicholas Pavlidis; A Triantafillidis; Paris A Kosmidis
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2002: Nicholas Pavlidis
Coexistence of pregnancy and malignancy.
The oncologist 2002;7(4):279-87.
2002: Evagelos N Liberopoulos; Sonia-Athina Karabina; Alexandros D Tselepis; Eleni Bairaktari; Costas Nicolaides; Nicholas Pavlidis; Moses Elisaf
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Oncology 2002;62(2):115-20.
2001: Maria Bai; John Vlachonikolis; Niki J Agnantis; Elena Tsanou; Sofia Dimou; Costas Nicolaides; Stella Stefanaki; Nicholas Pavlidis; Panagiotis Kanavaros; P Kanavarous
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(11):1105-13.
2001: Evangelos Briasoulis; Niki J Agnantis; P Zagorianakou; Sevasti Kamina; M Gorezi; Nicholas Pavlidis; Maria Bai
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study.
Journal of experimental & clinical cancer research : CR 2001;20(3):341-4.
2001: Dimosthenis V Skarlos; Epaminondas Samantas; Evangelos Briassoulis; E Panoussaki; Nicholas Pavlidis; Haralabos P Kalofonos; D Kardamakis; E Tsiakopoulos; Paris A Kosmidis; Dimitrios Tsavdaridis; John Tzitzikas; Pericles G Tsekeris; George Kouvatseas; Nikolaos Zamboglou; George Fountzilas
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1231-8.
2001: Moses S Elisaf; Eleni Bairaktari; Costas Nicolaides; B Kakaidi; Christos Tzallas; Afroditi Katsaraki; Nicholas Pavlidis
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(12):1510-3.
2001: J H M Schellens; Per Dombernowsky; J Cassidy; R Epelbaum; L Dirix; E H Cox; Jantien Wanders; F Calabresi; Robert Paridaens; S Monfardini; J Wolff; Walter J Loos; Jaap Verweij; Nicholas Pavlidis; Axel R Hanauske
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9.
Anti-cancer drugs 2001;12(7):583-90.
2001: A Bamias; G Baltayiannis; S Kamina; Michael Fatouros; E Lymperopoulos; N Agnanti; Epameinondas Tsianos; Nicholas Pavlidis
Rectal metastases from lobular carcinoma of the breast: report of a case and literature review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):715-8.
2001: George Fountzilas; Christos Papadimitriou; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Lia A Moulopoulos; Evangelia Razis; Haralabos P Kalofonos; Gerasimos Aravantinos; Evangelos Briassoulis; Pavlos Papakostas; K Abela; E Gogas; Paris A Kosmidis; Nicholas Pavlidis; Meletios A Dimopoulos
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: Evangelos Briasoulis; Eleni Andreopoulou; Christos Tolis; Eleni Bairaktari; Afroditi Katsaraki; Meletios A Dimopoulos; George Fountzilas; C Seferiadis; Nicholas Pavlidis
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting.
Cancer 2001;91(5):909-17.
2001: George Fountzilas; Christos Papadimitriou; Gerasimos Aravantinos; Costas Nicolaides; George P Stathopoulos; Dimitrios Bafaloukos; Haralambos Kalofonos; T Ekonomopoulos; Dimosthenis Skarlos; Nicholas Pavlidis; Athanassios Meletios Dimopoulos
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
2001: Evangelos Briasoulis; Nicholas Pavlidis
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy.
The oncologist 2001;6(2):153-61.
2001: Evangelia Razis; Athanassios Meletios Dimopoulos; Dimitrios Bafaloukos; Christos Papadimitriou; Anna Kalogera-Fountzila; Haralambos Kalofonos; Evangelos Briassoulis; Epaminondas Samantas; A Keramopoulos; Nicholas Pavlidis; Paris A Kosmidis; George Fountzilas
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.
Cancer investigation 2001;19(2):137-44.
2000: Evangelos Briasoulis; I Judson; Nicholas Pavlidis; P Beale; Jantien Wanders; Y Groot; G Veerman; M Schuessler; G Niebch; K Siamopoulos; Eleftheria Tzamakou; Dimitra Rammou; L Wolf; R Walker; Axel R Hanauske
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3535-44.
2000: Evangelos Briasoulis; Haralambos Kalofonos; Dimitrios Bafaloukos; Epaminondas Samantas; George Fountzilas; Nikolaos Xiros; Dimosthenis Skarlos; C Christodoulou; Paris A Kosmidis; Nicholas Pavlidis
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
2000: Moses S Elisaf; K Nakou; George Liamis; Nicholas Pavlidis
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1067-9.
2000: Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):899.
2000: Costas Nicolaides; Meletios A Dimopoulos; Epaminondas Samantas; Dimitrios Bafaloukos; Charalambos Kalofonos; George Fountzilas; Evangelia Razi; Paris A Kosmidis; Nicholas Pavlidis
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):873-5.
2000: Paris A Kosmidis; Nicolas Mylonakis; Dimosthenis Skarlos; Epaminondas Samantas; Meletios A Dimopoulos; C Papadimitriou; Charalabos Kalophonos; Nicholas Pavlidis; C Nikolaidis; C Papaconstantinou; George Fountzilas
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
2000: Teresa Gamucci; Robert Paridaens; B Heinrich; J H M Schellens; Nicholas Pavlidis; Jaap Verweij; Cristiana Sessa; S Kaye; MW Roelvink; Jantien Wanders; Axel R Hanauske
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: an EORTC-ECSG phase II clinical study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):793-7.
2000: Gerasimos Aravantinos; Meletios A Dimopoulos; Paris A Kosmidis; Dimitrios Bafaloukos; Christos Papadimitriou; Christos Kiamouris; Nicholas Pavlidis; K Sikiotis; Pavlos Papakostas; Dimosthenis V Skarlos
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):607-12.
2000: Dimitrios Pectasides; Theofanis Economopoulos; George Kouvatseas; A Antoniou; Z Zoumbos; Gerasimos Aravantinos; Costas Tsatalas; A Halikia; Costas Nikolaides; Christos Kiamouris; E Pappa; Nicholas Pavlidis; Dimosthenis Skarlos; George Fountzilas; Meletios A Dimopoulos
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
2000: Pelagia Katsimbri; A T Bamias; Marios E Froudarakis; I A Peponis; Stavros H Constantopoulos; Nicholas Pavlidis
Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2000;28(2):163-70.
2000: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; Spiros Papavramidis; A Bousoulegas; George Basdanis; Eleftherios Giannoulis; J Dokmetzioglou; C Katsohis; E Nenopoulou; N Karvounis; Evangelos Briassoulis; Gerasimos Aravantinos; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
2000: P Katsimbri; A Bamias; Nicholas Pavlidis
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.
European journal of cancer (Oxford, England : 1990) 2000;36(6):766-71.
2000: Paris A Kosmidis; Nicolas Mylonakis; Athanassios Meletios Dimopoulos; Nicholas Pavlidis; George Fountzilas; Epaminondas Samantas; K Dimitriadis; Charalabos Kalophonos; Dimitrios Tsavdaridis; Dimosthenis Skarlos
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Seminars in oncology 2000;27(1 Suppl 2):3-8.
2000: Evangelos Briasoulis; Marios E Froudarakis; H J Milionis; I Peponis; Stavros H Constantopoulos; Nicholas Pavlidis
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.
Respiration; international review of thoracic diseases 2000;67(6):680-3.
2000: Nicholas Pavlidis
Cancer and pregnancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():247-53.
2000: Nicholas Pavlidis; Steinar Aamdal; A Awada; Hilary Calvert; Pierre Fumoleau; Roberto Sorio; C Punt; J Verweij; Allan van Oosterom; Rudolf Morant; Jantien Wanders; Axel R Hanauske
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
Cancer chemotherapy and pharmacology 2000;46(2):167-71.
2000: George Fountzilas; Costas Nicolaides; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Haralambos Kalofonos; Georgios Fotios Samelis; Gerasimos Aravantinos; Nicholas Pavlidis
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.
Cancer investigation 2000;18(6):503-9.
2000: Jim Janinis; THEODORE GIANNAKAKIS; A Athanasiades; George Fountzilas; Dimitrios Bafaloukos; Paris A Kosmidis; K Nikolaides; Nicholas Pavlidis; Dimosthenis Skarlos
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
Tumori 2000;86(1):37-41.
1999: Evangelos Briasoulis; Vasilis Karavasilis; Dimitri Anastasopoulos; Eleftheria Tzamakou; George Fountzilas; Dimitra Rammou; V Kostadima; Nicholas Pavlidis
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):701-6.
1999: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; A Liaros; Eleni Athanassiou; Nicholas V Dombros; Christos Dervenis; George Basdanis; Orestis G Gamvros; A Souparis; Evangelos Briasoulis; Epaminondas Samantas; Angelos M Kappas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
1999: George Fountzilas; George P Stathopoulos; Costas Nicolaides; Anna Kalogera-Fountzila; Haralambos Kalofonos; Angelos Nikolaou; Christos Bacoyiannis; Epaminondas Samantas; Christos Papadimitriou; Paris A Kosmidis; John Daniilidis; Nicholas Pavlidis
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):475-8.
1999: Epaminondas Samantas; Dimosthenis V Skarlos; Dimitrios Pectasides; P Nicolaides; Haralambos Kalofonos; Nicolas Mylonakis; T h Vardoulakis; Paris A Kosmidis; Nicholas Pavlidis; George Fountzilas
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):159-68.
1999: Dimosthenis V Skarlos; Epaminondas Samantas; Dimitrios Pectasides; Nicholas Pavlidis; Charalambos Kalofonos; George Klouvas; E Panoussaki; E Tsiakopoulos; N Poulakis; George Fountzilas
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
American journal of clinical oncology 1999;22(1):87-93.
1998: Dimitrios Stefanou; AV Nonni; Niki J Agnantis; S E Athanassiadou; E Briassoulis; Nicholas Pavlidis
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Anticancer research 1998;18(6B):4673-81.
1998: Theofanis Economopoulos; George Fountzilas; Akrivi Kostourou; John Daniilidis; Nicholas Pavlidis; H Andreopoulou; Angelos Nicolaou; Efstathios Papageorgiou; Sofia Mellou; John Dervenoulas; N Stathakis
Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Anticancer research 1998;18(6B):4655-60.
1998: George Fountzilas; Costas Nicolaides; Gerasimos Aravantinos; Dimosthenis Skarlos; Paris A Kosmidis; Pavlos Papakostas; George P Stathopoulos; E Kontostolis; Dimitrios Bafaloukos; Nicholas Pavlidis
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: George Fountzilas; Athanassios Meletios Dimopoulos; Christos Papadimitriou; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; A Athanassiades; Costas Nicolaides; A Keramopoulos; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
1998: Evangelos Briasoulis; N Tsavaris; George Fountzilas; A Athanasiadis; P Kosmidis; D Bafaloukos; D Skarlos; Epaminondas Samantas; Nicholas Pavlidis
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study.
Oncology 1998;55(5):426-30.
1998: Costas Nicolaides; George Fountzilas; Nicholas C Zoumbos; Dimosthenis Skarlos; Paris A Kosmidis; Dimitrios Pectasides; Athanasios Karabelis; THEODORE GIANNAKAKIS; Argyris Symeonidis; A Papadopoulos; F Antoniou; Nicholas Pavlidis
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Oncology 1998;55(5):405-15.
1998: Meletios A Dimopoulos; Marianna Papadopoulou; Eleni Andreopoulou; Christos Papadimitriou; Nicholas Pavlidis; Gerasimos Aravantinos; A Aspropotamitis; A Anagnostopoulos; George Fountzilas; Stylianos Michalas; D Pectacides
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Gynecologic oncology 1998;70(1):70-4.
1998: Costas Nicolaides; THEODORE GIANNAKAKIS; Dimosthenis Skarlos; AP Athanassiadis; George Fountzilas; D Damigos; Nicholas Pavlidis
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Journal of experimental & clinical cancer research : CR 1998;17(1):71-5.
1998: Anna Kalogera-Fountzila; Paris A Kosmidis; Christos Bacoyiannis; Angelos Nicolaou; Epaminondas Samantas; Evangelos Briassoulis; Nicholas Pavlidis; Dimosthenis Skarlos; John Daniilidis; George Fountzilas
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer.
Anticancer research 1998;18(1B):587-93.
1998: Dimitrios Bafaloukos; George Fountzilas; Dimosthenis Skarlos; Nicholas Pavlidis; Charalambos Bakoyiannis; N Karvounis; Paris A Kosmidis
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
Oncology 1998;55(1):48-52.
1997: George Fountzilas; A Athanassiades; THEODORE GIANNAKAKIS; Evangelos Briasoulis; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; A Onienaoum; Haralambos Kalofonos; Dimitrios Pectasides; Eleni Andreopoulou; Christina Bamia; Paris A Kosmidis; Nicholas Pavlidis; Dimosthenis Skarlos
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
1997: George Fountzilas; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Evangelos Briassoulis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-28-S19-32.
1997: George Fountzilas; S Vasilaros; Dimitrios Koukouras; N Malamos; Dimitrios Pectasides; Adamos Adamou; E Nenopoulou; K Kiriakou; Ioanna Zouvani; K Katsohis; Angelos M Kappas; C Skopa; C Semoglou; E Fahantidis; Christos Konstantaras; E Vasilaki; Theofanis Economopoulos; H Bacoyiannis; Dimitrios Bafaloukos; Evangelia Razi; A Polichronis; G Androulakis; T Papaioannou; Nicholas Pavlidis; Paris A Kosmidis
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.
Anticancer research 1997;17(6D):4681-9.
1997: George Fountzilas; AP Athanassiadis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Briasoulis; Nicholas V Dombros; Ioannis Ioannidis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Dimosthenis V Skarlos; Gerasimos Aravantinos; Paris A Kosmidis; AP Athanassiadis; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; S Karphathios; Pavlos Papakostas; Christina Bamia; George Fountzilas
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
1997: Nicolas Tsavaris; N Primikirios; Nicolas Mylonakis; G Varouchakis; Theodosios Dosios; Nicholas Pavlidis; Dimosthenis Skarlos; T Tasopoulos; J Dritsas; Paris A Kosmidis
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Anticancer research 1997;17(5B):3799-802.
1997: Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis
Megestrol activity in recurrent adult type granulosa cell tumour of the ovary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):811-2.
1997: Paris A Kosmidis; Nicolas Mylonakis; George Fountzilas; Epaminondas Samantas; AP Athanassiadis; Nicholas Pavlidis; Dimosthenis Skarlos
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Seminars in oncology 1997;24(4 Suppl 12):S12-30-S12-33.
1997: Paris A Kosmidis; Nicolas Mylonakis; George Fountzilas; Epaminondas Samantas; A Athanasiadis; Eleni Andreopoulou; Nicholas Pavlidis; Dimosthenis Skarlos
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):697-9.
1997: George Fountzilas; Dimosthenis Skarlos; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Angelos Nicolaou; Nicholas V Dombros; Evangelos Briasoulis; M Dinopoulou; George P Stathopoulos; Nicholas Pavlidis; Paris A Kosmidis; John Daniilidis
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1997: Costas Nicolaides; George Klouvas; George Fountzilas; AP Athanassiadis; Dimosthenis Skarlos; Epaminondas Samantas; P Kosmidis; Nicolas Mylonakis; Nicholas Pavlidis
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).
Journal of experimental & clinical cancer research : CR 1997;16(1):91-4.
1996: L Y Dirix; F Tonnesen; J Cassidy; R Epelbaum; W W ten Bokkel Huinink; Nicholas Pavlidis; R Sorio; T Gamucci; I Wolff; A Te Velde; J Lan; Jaap Verweij
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group.
European journal of cancer (Oxford, England : 1990) 1996;32A(11):2019-22.
1996: Paris A Kosmidis; Nicolas Tsavaris; D Skarlos; D Theocharis; Epaminondas Samantas; Nicholas Pavlidis; Evangelos Briassoulis; George Fountzilas
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2682-7.
1996: Dimitrios Pectasides; Nicholas Pavlidis; L Gogou; F Antoniou; Costas Nicolaides; D Tsikalakis
Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
American journal of clinical oncology 1996;19(5):459-64.
1996: Moses Elisaf; Eleni Bairaktari; Costas Nicolaides; George Fountzilas; Christos Tzallas; Kostas Siamopoulos; Orestes Tsolas; Nicholas Pavlidis
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.
Anticancer research 1996;16(5A):2725-8.
1996: Nicholas Pavlidis; A R Hanauske; T Gamucci; J Smyth; M Lehnert; A te Velde; J Lan; Jaap Verweij
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):529-31.
1996: Paris A Kosmidis; Nicolas Mylonakis; George Fountzilas; Nicholas Pavlidis; Epaminondas Samantas; A Karabelis; K Kattis; D Skarlos
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):517-20.
1996: Dimitrios Bafaloukos; Nicholas Pavlidis; George Fountzilas; D Skarlos; George Klouvas; P Makrantonakis; THEODORE GIANNAKAKIS; Nicolas Tsavaris; Paris A Kosmidis
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
American journal of clinical oncology 1996;19(3):296-300.
1996: George Fountzilas; K Gossios; A Zisiadis; E Svarna; D Skarlos; Nicholas Pavlidis
Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy.
Medical and pediatric oncology 1996;26(5):305-17.
1996: D V Skarlos; Gerasimos Aravantinos; Paris A Kosmidis; Nicholas Pavlidis; K Gennatas; M Beer; Nicolas Mylonakis; P Makrantonakis; George Klouvas; S Karpathios; H Linardou; Christos Konstantaras; George Fountzilas
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):421-8.
1996: Nicholas Pavlidis; Costas Nicolaides; AP Athanassiadis; K Beriatou; D Skarlos; THEODORE GIANNAKAKIS; Paris A Kosmidis; N Karvounis; George Fountzilas
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):159-62.
1996: George Fountzilas; A Polichronis; K Katsohis; K Gennatas; D Toussis; D Skarlos; Paris A Kosmidis; S Vassilaros; C Semoglou; THEODORE GIANNAKAKIS; E Fahantidis; George Klouvas; Nicolas Tsavaris; Christos Konstantaras; P Makrantonakis; Christos Kolotas; Nikolaos Zamboglou; S Tsiliakos; D Hainoglou; Nicolas Mylonakis; Nicholas Pavlidis
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):137-46.
1996: John Kalef-Ezra; Nicholas Pavlidis; George Klouvas; A Karantanas; I Hatzikonstantinou; D Glaros
Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.
Breast cancer research and treatment 1996;37(2):161-8.
1996: Nicholas Pavlidis; Costas Nicolaides; Eleni Bairaktari; John Kalef-Ezra; AP Athanassiadis; C Seferiadis; George Fountzilas
Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.
The International journal of biological markers 1996;11(1):6-11.
1995: Nicholas Pavlidis; Evangelos Briassoulis; M Bai; George Fountzilas; Niki J Agnantis
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
Anticancer research 1995;15(6B):2563-7.
1995: Nicholas Pavlidis; Eleni Bairaktari; John Kalef-Ezra; Costas Nicolaides; C Seferiadis; George Fountzilas
Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients.
The International journal of biological markers 1995;10(2):75-80.
1995: Nicholas Pavlidis; George Klouvas; M Tsokos; M Bai; Haralampos M Moutsopoulos
Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders--a paraneoplastic lymphocytic vasculitis of the skin.
Leukemia & lymphoma 1995;16(5-6):477-82.
1995: George Fountzilas; D Skarlos; C Katsohis; Nicholas Pavlidis; THEODORE GIANNAKAKIS; Dimitrios Bafaloukos; E Fahantidis; George Klouvas; M Beer; Paris A Kosmidis
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study.
Medical and pediatric oncology 1995;24(1):23-8.
1994: Nicholas Pavlidis; Costas Nicolaides; George Klouvas; Evangelos Briassoulis
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literature.
Journal of chemotherapy (Florence, Italy) 1994;6(6):417-22.
1994: P Kiriakogiani-Psaropoulou; V Malamou-Mitsi; U Martinopoulou; S Legaki; N Tamvakis; E Vrettou; George Fountzilas; D Skarlos; Paris A Kosmidis; Nicholas Pavlidis
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):353-64.
1994: Nicolas Tsavaris; Nicolas Mylonakis; N Karvounis; Christos Bacoyiannis; Evangelos Briasoulis; D Skarlos; Nicholas Pavlidis; G Stamatelos; Paris A Kosmidis
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):299-303.
1994: Paris A Kosmidis; Epaminondas Samantas; G Fountzilas; Nicholas Pavlidis; F Apostolopoulou; D Skarlos
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Seminars in oncology 1994;21(3 Suppl 6):23-30.
1994: Theofanis Economopoulos; N Stathakis; C Alexopoulos; Nicholas Pavlidis; M Constantinidou; Evangelos Briassoulis; Efstathios Papageorgiou; J Dervenoulas; Vassiliki Pappa; M Vaslamatzis
Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Haematologica 1994;79(3):273-6.
1994: Nicholas Pavlidis; M Elisaf; M Bai; C Tolis; C Papadimitriou
Primary lymphoma of the pericardium: report on a "cured" case and review of the literature.
Medical and pediatric oncology 1994;22(4):287-91.
1994: George Fountzilas; D Skarlos; THEODORE GIANNAKAKIS; A Athanasiades; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Christina Bamia; Nicholas Pavlidis; Paris A Kosmidis
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):965-9.
1994: Nicholas Pavlidis; John Kalef-Ezra; Evangelos Briassoulis; D Skarlos; Paris A Kosmidis; K Saferiadis; Eleni Bairaktari; Dimitrios Bafaloukos; A Maravegias; D Theoharis
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Medical and pediatric oncology 1994;22(3):162-7.
1993: Nicholas Pavlidis; George Klouvas; Costas Nicolaides; A Karantanas; M Beer; George Fountzilas
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.
Lung cancer (Amsterdam, Netherlands) 1993;10(1-2):85-9.
1993: Nikolaos E Stavropoulos; E Ioackim-Velogianni; K Sidoni; Dimitrios Stefanou; George Klouvas; Nicholas Pavlidis
Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen.
British journal of urology 1993;71(3):309-12.
1993: D V Skarlos; George Fountzilas; Nicholas Pavlidis; M Beer; P Makrantonakis; Gerasimos Aravantinos; P Pantelakos; Nicolas Tsavaris; N Karpasitis; Paris A Kosmidis
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
1992: Nicholas Pavlidis; Paris A Kosmidis; D Skarlos; Evangelos Briassoulis; M Beer; D Theoharis; Dimitrios Bafaloukos; A Maraveyas; George Fountzilas
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(8):631-4.
1992: Nicholas Pavlidis; C Petris; Evangelos Briassoulis; George Klouvas; C Psilas; J Rempapis; G Petroutsos
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
Cancer 1992;69(12):2961-4.
1992: John Kalef-Ezra; D Glaros; George Klouvas; J Hatzikonstantinou; A Karantanas; Kostas Siamopoulos; Nicholas Pavlidis
New evidence that tamoxifen does not induce osteoporosis: a nuclear activation analysis and absorptiometry study.
The British journal of radiology 1992;65(773):417-20.
1992: Nicholas Pavlidis; M N Manoussakis; G S Germanidis; Haralampos M Moutsopoulos
Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
Medical and pediatric oncology 1992;20(1):26-31.
1992: Nicholas Pavlidis; Alexandros A Drosos; C Papadimitriou; N Talal; Haralampos M Moutsopoulos
Lymphoma in Sjogren's syndrome.
Medical and pediatric oncology 1992;20(4):279-83.
1992: Nicholas Pavlidis; Evangelos Briassoulis; George Klouvas; M Bai
Is interferon-a an active agent in Castleman's disease?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(1):85-6.
1992: Theofanis Economopoulos; N Asprou; N Stathakis; George Fountzilas; Nicholas Pavlidis; S Papaspyrou; J Dervenoulas; M Belia; Efstathios Papageorgiou; D Theoharis
Primary extranodal non-Hodgkin's lymphoma of the head and neck.
Oncology 1992;49(6):484-8.
1991: George Fountzilas; D Skarlos; Nicholas Pavlidis; P Makrantonakis; Nicolas Tsavaris; Anna Kalogera-Fountzila; THEODORE GIANNAKAKIS; M Beer; Paris A Kosmidis
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study.
Tumori 1991;77(3):232-6.
1991: Nicholas Pavlidis; George Klouvas; P Kyparissiadis; A Sourla; C Papademetriou
Extraskeletal Ewing's sarcoma. Presentation of two cases and review of the literature.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1991;17(3):308-12.
1990: P D Katsikis; Nicholas Pavlidis; N M Papadopoulos; M Bai; Haralampos M Moutsopoulos
Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.
Anticancer research 1990;10(6):1719-24.
1990: Nicholas Pavlidis; A D Sourla; N G Nikolaou; C F Tolis; V D Mitsi
Neglected cases of papillary and follicular thyroid carcinoma. Occurrence of subcutaneous scalp metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):175-9.
1990: Nicholas Pavlidis; Fotini N Skopouli; M C Bai; C L Bourantas
A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease).
Medical and pediatric oncology 1990;18(4):333-5.
1987: Stavros H Constantopoulos; Vassiliki Malamou-Mitsi; John A Goudevenos; M P Papathanasiou; Nicholas Pavlidis; C S Papadimitriou
High incidence of malignant pleural mesothelioma in neighbouring villages of Northwestern Greece.
Respiration; international review of thoracic diseases 1987;51(4):266-71.